Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Only the First day today!!

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Feb 28, 2021 12:18pm

289 Views

Post# 32681540

RE:RE:Only the First day today!!

Well it's almost Monday Morning I can't wait to see how this flys tomorrow, If your planning on getting in I'd put your buys in now but it closed at 0.065, You might want to start your buy at 0.070 or you may miss the boat. We havent even had news yet.

Chritters wrote: Just remember Last Friday Markets took a Dump everything was red and yet KLY was flying off the charts, All you have to do is look at Fridays Volume!!

Rezjen wrote: Imagine what happens when they start releasing news of the work they did past 6-7 months....picking up all that I can ... Monday will be the run to 20c